Amgen Inc. (AMGN)
NASDAQ: AMGN · IEX Real-Time Price · USD
331.73
+0.76 (0.23%)
Jul 19, 2024, 2:11 PM EDT - Market open

Amgen Revenue

Amgen had revenue of $29.53B in the twelve months ending March 31, 2024, with 12.76% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.45B with 21.98% year-over-year growth. In the year 2023, Amgen had annual revenue of $28.19B with 7.09% growth.

Revenue (ttm)
$29.53B
Revenue Growth
+12.76%
P/S Ratio
5.99
Revenue / Employee
$1,106,067
Employees
26,700
Market Cap
177.99B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 202025.42B2.06B8.83%
Dec 31, 201923.36B-385.00M-1.62%
Dec 31, 201823.75B898.00M3.93%
Dec 31, 201722.85B-142.00M-0.62%
Dec 31, 201622.99B1.33B6.14%
Dec 31, 201521.66B1.60B7.97%
Dec 31, 201420.06B1.39B7.43%
Dec 31, 201318.68B1.41B8.17%
Dec 31, 201217.27B1.68B10.80%
Dec 31, 201115.58B529.00M3.51%
Dec 31, 201015.05B411.00M2.81%
Dec 31, 200914.64B-361.00M-2.41%
Dec 31, 200815.00B232.00M1.57%
Dec 31, 200714.77B503.00M3.53%
Dec 31, 200614.27B1.84B14.79%
Dec 31, 200512.43B1.88B17.82%
Dec 31, 200410.55B2.19B26.26%
Dec 31, 20038.36B2.83B51.29%
Dec 31, 20025.52B1.51B37.54%
Dec 31, 20014.02B386.30M10.64%
Dec 31, 20003.63B289.30M8.66%
Dec 31, 19993.34B621.90M22.88%
Dec 31, 19982.72B317.20M13.21%
Dec 31, 19972.40B161.20M7.20%
Dec 31, 19962.24B299.90M15.46%
Dec 31, 19951.94B292.00M17.72%
Dec 31, 19941.65B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Elevance Health 171.75B
Pfizer 55.09B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Danaher 22.52B
Revenue Rankings